Macquarie Group’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,454
Closed -$39K 1918
2022
Q3
$39K Hold
4,454
﹤0.01% 2017
2022
Q2
$56K Hold
4,454
﹤0.01% 2016
2022
Q1
$84 Hold
4,454
﹤0.01% 2007
2021
Q4
$156K Hold
4,454
﹤0.01% 1816
2021
Q3
$163K Buy
+4,454
New +$175K ﹤0.01% 1843
2021
Q1
Sell
-5,513
Closed -$176K 2474
2020
Q4
$176K Sell
5,513
-1,658
-23% -$51K ﹤0.01% 1706
2020
Q3
$232K Buy
7,171
+187
+3% +$5.83K ﹤0.01% 1581
2020
Q2
$193K Hold
6,984
﹤0.01% 1554
2020
Q1
$125K Buy
6,984
+4,984
+249% +$120K ﹤0.01% 1569
2019
Q4
$51K Hold
2,000
﹤0.01% 1849
2019
Q3
$36K Hold
2,000
﹤0.01% 1830
2019
Q2
$44K Hold
2,000
﹤0.01% 1742
2019
Q1
$61K Hold
2,000
﹤0.01% 1566
2018
Q4
$46K Buy
+2,000
New +$62.2K ﹤0.01% 1610

Other funds holding HCM

Macquarie Group's HCM Position: Q4 2022 in Review

Macquarie Group sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 4,454 shares — an estimated $39K sold.

Macquarie Group first reported a position in HCM in Q4 2018 and held it in 14 quarters. The position peaked at $232K in Q3 2020. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Macquarie Group reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 4,454 HUTCHMED shares in Q4 2022, an estimated $39K.
  • Macquarie Group first reported a position in HUTCHMED in Q4 2018 and held it in 14 quarters.
  • Macquarie Group's HUTCHMED position peaked at $232K in Q3 2020.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.